Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Cooling Technology Helps Prevent Oral Mucositis

By HospiMedica International staff writers
Posted on 24 Feb 2021
A single-use intraoral device cools the back of the mouth where arteries enter the oral cavity, preventing the mucositis that follows cancer treatments. More...


The BrainCool (Lund, Sweden) Cooral System features a disposable, thermostatically controlled intra-oral device that comprises closed conduits with continuously circulating water to evenly distribute the hypothermic medium to the oral mucosa, via a mouthpiece inserted into the patient’s mouth. As the consistently controlled circulated water reaches a steady temperature of 8°C, cooling the oral mucosa, it leads to reduced blood flow and exposure of tissue to chemotherapeutic agents, thus preventing soreness, erythema, and painful ulcerative lesions.

“Intra-oral cooling to prevent or mitigate oral mucositis represents an important, safe, and effective technology for selected cohorts of oncology patients,” said Douglas E. Peterson, DMD, PhD, a consultant to BrainCool. “Based on my several decades of research and clinical experience relative to oral mucositis caused by cancer therapies, reduction of the severe pain and ulceration associated with the condition is key, especially for patients on aggressive treatment schedules for whom delays due to oral mucositis may be life-threatening.”

“Cooling is a well-known method to prevent this chemo-induced side effect, but it is only limitedly applied in clinics because using ice water is painful for the patient and poorly tolerated during the entire treatment time. Risk of infection can also be a deterrent,” said Professor Roger Henriksson, MD, PhD, of the University of Umeå (Sweden). “Oncologists all over the world are in need of a better cooling method to prevent oral mucositis and thus improving the quality of life for the patients. The Cooral System is an important step forward and much-needed technology.”

Oral Mucositis has been reported as the singlemost debilitating complication of cancer therapy, and can be present in combination with additional incapacitating symptoms, such as intractable oral pain, undernourishment, weight loss, and impaired quality of life. It can also represent a portal of entry for systemic infections that can lead to sepsis and death. Taken together, these symptoms, along with their related sequelae, can result in hospitalization and increased costs for healthcare systems.

Related Links:
BrainCool


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
ECG Management System
NEMS Web
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.